ADVI in the News

Cell and Gene Federal And State Policy

ADVI’s Alicia Silver Discusses the Cell and Gene Therapy Landscape with the Empowered Patient Podcast

Cell and Gene Strategic Analytics, Value and Economics

ADVI Health’s Expertise on CAR-T Disparities Featured in STAT

Cell and Gene Strategic Analytics, Value and Economics

Peter Kardel Included in Specialty Pharmacy Continuum

Cell and Gene

ADVI’s Alicia Silver Featured on Prescription for Better Access Podcast

Earlier this month, Alicia Silver, director of market access, cell and gene therapy was featured on the Prescription for Better Access Podcast to provide insight on the challenges of access and affordability in cell and gene therapies.

Cell and Gene Inflation Reduction Act Oncology/biologics Pharmaceuticals and Biotech Federal And State Policy

Marc Samuels Shares Insight on Important 2024 Regulatory Decisions with Pharma’s Almanac

In this Pharma's Almanac article, ADVI’s Marc Samuels, CEO and president, shares his insights on the most significant regulatory decisions stakeholders should consider as we look ahead to 2024.

Cell and Gene Oncology/biologics Pharmaceuticals and Biotech

ADVI and Mix Talent Present: Cell and Gene with Gamida Cell and Zevra Therapeutics

Cell and Gene Oncology/biologics Pharmaceuticals and Biotech

ADVI and Mix Talent Present: Cell and Gene with BridgeBio and Propel Biosciences